Payment overview · 2025
General Payments
$22.42
1 reported records · 1 companies
Healthcare provider profile · identity verified
Roberto Z. Gonzalez, MD
Allopathic & Osteopathic Physicians|Internal Medicine · PETALUMA, CA · NPI 1801970892
Verified facts
What the public records show
CMS Open Payments records show Roberto Z. Gonzalez, MD received $22.42 in general payments during 2025 across 1 reported records.
Invivyd Inc accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Invivyd Inc | Unresolved — no canonical attribution shown | $22.42 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $22.42 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| PEMGARDA Normalized: pemgarda |
Biological | Invivyd Inc | $22.42 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 563 | 186 |
| Levothyroxine Sodium | Levothyroxine Sodium | 460 | 133 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 432 | 73 |
| Lisinopril | Lisinopril | 365 | 123 |
| Amlodipine Besylate | Amlodipine Besylate | 346 | 120 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 217 | 94 |
| Famotidine | Famotidine | 201 | 58 |
| Omeprazole | Omeprazole | 195 | 64 |
| Losartan Potassium | Losartan Potassium | 190 | 67 |
| Tamsulosin Hcl | Tamsulosin Hcl | 184 | 56 |
| Lorazepam | Lorazepam | 175 | 36 |
| Gabapentin | Gabapentin | 165 | 55 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 160 | 58 |
| Hydrochlorothiazide | Hydrochlorothiazide | 159 | 51 |
| Atenolol | Atenolol | 147 | 43 |
| Simvastatin | Simvastatin | 147 | 48 |
| Trazodone Hcl | Trazodone Hcl | 146 | 39 |
| Fluticasone Propionate | Fluticasone Propionate | 128 | 43 |
| Pantoprazole Sodium | Pantoprazole Sodium | 125 | 37 |
| Allopurinol | Allopurinol | 123 | 39 |
| Ibuprofen | Ibuprofen | 115 | 32 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 115 | 19 |
| Metformin Hcl Er | Metformin Hcl | 101 | 42 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 97 | 36 |
| Metoprolol Tartrate | Metoprolol Tartrate | 88 | 32 |
| Zolpidem Tartrate | Zolpidem Tartrate | 86 | 21 |
| Metoprolol Succinate | Metoprolol Succinate | 85 | 27 |
| Alvesco | Ciclesonide | 81 | 25 |
| Prednisone | Prednisone | 76 | 34 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 76 | 42 |
| Terazosin Hcl | Terazosin Hcl | 74 | 25 |
| Furosemide | Furosemide | 71 | 28 |
| Meloxicam | Meloxicam | 66 | 18 |
| Quetiapine Fumarate | Quetiapine Fumarate | 66 | 19 |
| Oxycodone Hcl | Oxycodone Hcl | 64 | 19 |
| Alendronate Sodium | Alendronate Sodium | 63 | 26 |
| Hydrocortisone | Hydrocortisone | 61 | 29 |
| Ondansetron Odt | Ondansetron | 59 | 18 |
| Sertraline Hcl | Sertraline Hcl | 58 | 21 |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 58 | 17 |
| Metformin Hcl | Metformin Hcl | 55 | 21 |
| Baclofen | Baclofen | 54 | 11 |
| Fluoxetine Hcl | Fluoxetine Hcl | 54 | 17 |
| Mupirocin | Mupirocin | 54 | 24 |
| Pradaxa | Dabigatran Etexilate Mesylate | 54 | 28 |
| Escitalopram Oxalate | Escitalopram Oxalate | 51 | 17 |
| Potassium Chloride | Potassium Chloride | 51 | 15 |
| Clopidogrel | Clopidogrel Bisulfate | 49 | 16 |
| Lactulose | Lactulose | 49 | 12 |
| Acyclovir | Acyclovir | 48 | 22 |
| Torsemide | Torsemide | 46 | 17 |
| Citalopram Hbr | Citalopram Hydrobromide | 45 | 12 |
| Temazepam | Temazepam | 45 | suppressed |
| Cefadroxil | Cefadroxil | 44 | 34 |
| Clobetasol Propionate | Clobetasol Propionate | 44 | 22 |
| Montelukast Sodium | Montelukast Sodium | 44 | 15 |
| Ozempic | Semaglutide | 44 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 42 | 18 |
| Lovastatin | Lovastatin | 42 | 14 |
| Alprazolam | Alprazolam | 41 | suppressed |
| Amoxicillin | Amoxicillin | 41 | 20 |
| Tramadol Hcl | Tramadol Hcl | 41 | suppressed |
| Adacel Tdap | Diph,pertuss(Acell),tet Vac/Pf | 36 | 36 |
| Diazepam | Diazepam | 36 | suppressed |
| Bupropion Xl | Bupropion Hcl | 35 | suppressed |
| Fluocinonide | Fluocinonide | 35 | 15 |
| Propranolol Hcl | Propranolol Hcl | 35 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 35 | 11 |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 33 | 17 |
| Glipizide | Glipizide | 33 | 11 |
| Spironolactone | Spironolactone | 33 | 14 |
| Breyna | Budesonide/Formoterol Fumarate | 32 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 31 | 13 |
| Donepezil Hcl | Donepezil Hcl | 30 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 30 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 28 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 27 | suppressed |
| Clonazepam | Clonazepam | 27 | suppressed |
| Eliquis | Apixaban | 27 | suppressed |
| Jardiance | Empagliflozin | 27 | suppressed |
| Atenolol-Chlorthalidone | Atenolol/Chlorthalidone | 26 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 26 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 26 | 11 |
| Nortriptyline Hcl | Nortriptyline Hcl | 25 | suppressed |
| Pregabalin | Pregabalin | 25 | suppressed |
| Carvedilol | Carvedilol | 24 | suppressed |
| Mirtazapine | Mirtazapine | 24 | suppressed |
| Chlorthalidone | Chlorthalidone | 23 | suppressed |
| Trospium Chloride | Trospium Chloride | 23 | suppressed |
| Digoxin | Digoxin | 22 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 21 | 14 |
| Estradiol | Estradiol | 21 | 11 |
| Finasteride | Finasteride | 21 | suppressed |
| Glimepiride | Glimepiride | 21 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 21 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 21 | suppressed |
| Naproxen | Naproxen | 21 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 21 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 21 | suppressed |
| Veo Insulin Syringe | Syringe-Needle,insulin,0.5 Ml | 21 | suppressed |
| Betamethasone Diprop Augmented | Betamethasone/Propylene Glyc | 20 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 19 | suppressed |
| Nitroglycerin | Nitroglycerin | 19 | suppressed |
| Nystatin | Nystatin | 19 | suppressed |
| Retin-A | Tretinoin | 19 | suppressed |
| Azithromycin | Azithromycin | 18 | 17 |
| Cephalexin | Cephalexin | 18 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 17 | suppressed |
| Hydromorphone Hcl | Hydromorphone Hcl | 17 | suppressed |
| Metronidazole | Metronidazole | 17 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 17 | suppressed |
| Xifaxan | Rifaximin | 17 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 16 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 15 | suppressed |
| Methadone Hcl | Methadone Hcl | 15 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 15 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 15 | suppressed |
| Prochlorperazine Maleate | Prochlorperazine Maleate | 15 | suppressed |
| Rizatriptan | Rizatriptan Benzoate | 15 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 15 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 14 | suppressed |
| Risperidone | Risperidone | 14 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 13 | suppressed |
| Ezetimibe | Ezetimibe | 13 | suppressed |
| Humulin N | Insulin Nph Human Isophane | 13 | suppressed |
| Humulin N Kwikpen | Insulin Nph Human Isophane | 13 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 13 | 11 |
| Colchicine | Colchicine | 12 | suppressed |
| Memantine Hcl | Memantine Hcl | 12 | suppressed |
| Testosterone | Testosterone | 12 | suppressed |
| Yuvafem | Estradiol | 12 | suppressed |
| Fluorouracil | Fluorouracil | 11 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 11 | suppressed |
| Nabumetone | Nabumetone | 11 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 11 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $22.42 · 1 records | Invivyd Inc | PEMGARDA | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error